SEC Form 4 · accession 0001179110-16-020662
Inotiv, Inc. · NOTVQ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jacqueline M Lemke
Officer — President and CEO · Director
Period of report
Feb 29, 2016
Accepted (ET)
Mar 2, 2016 · 5:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000720154
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Feb 29, 2016 | P | 4,000 | $1.1854 | A | 60,685 | D | |
| Common SharesF1,F2 | Feb 29, 2016 | P | 6,000 | $1.17 | A | 9,000 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.13 to $1.20, inclusive. The reporting person undertakes to provide Bioanalytical Systems, Inc., any security holder of Bioanalytical Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- F2The reporting person acts as custodian for accounts which hold these shares for the benefit of the reporting person's minor children. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.